v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
REVENUES:        
Product revenue $ 6,525,233 $ 4,620,841 $ 10,018,114 $ 8,627,139
License and other revenue 35,709 35,709 71,417 71,417
Total Revenues 6,560,942 4,656,550 10,089,531 8,698,556
OPERATING EXPENSES        
Cost of product revenue (exclusive of amortization expense shown below) 10,491,236 9,645,662 19,896,415 21,888,410
Research and development 516,986 1,040,427 1,387,621 2,005,998
Plasma center operating expenses 594,113 1,738,128 1,248,599 3,571,902
Amortization of intangibles 211,234 211,234 422,469 422,469
Selling, general and administrative 6,086,047 5,438,480 11,681,517 10,759,661
TOTAL OPERATING EXPENSES 17,899,616 18,073,931 34,636,621 38,648,440
LOSS FROM OPERATIONS (11,338,674) (13,417,381) (24,547,090) (29,949,884)
OTHER INCOME (EXPENSE):        
Interest and other income 209,808 33,070 337,207 59,616
Interest expense (2,072,578) (1,359,188) (3,613,085) (2,682,340)
Loss on extinguishment of debt 0 0 (9,962,495) 0
Gain on transfer of plasma center assets 0 0 11,527,421 0
Other (expense) income (10,428) (4,332) (21,785) 2,635
Other expense, net (1,873,198) (1,330,450) (1,732,737) (2,620,089)
NET LOSS $ (13,211,872) $ (14,747,831) $ (26,279,827) $ (32,569,973)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (0.25) $ (0.35) $ (0.53) $ (0.74)
WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted 52,206,204 42,712,168 49,295,805 44,007,409

Source